PF-Atlas › Clinical Trials › NCT02884622

DNA Methylation and Lung Disease in Cystic Fibrosis

nasal epithelial · Not specified

Registry ID
NCT02884622
Phase
Not specified
Status
Completed
Drug / intervention
nasal epithelial
Sponsor
University Hospital, Montpellier
Start
2013-06

About this trial

nasal epithelial is evaluated in NCT02884622, a idiopathic pulmonary fibrosis study sponsored by University Hospital, Montpellier. Current status: Completed.

View NCT02884622 on ClinicalTrials.gov →

Medical disclaimer. This page summarizes public trial data for NCT02884622 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.